Sponsor of the Day:
Jerkmate
https://manufacturingchemist.com/sygnature-discovery-strengthens-in-vivo-pharmacology-leadership-with
Sygnature Discovery strengthens in vivo pharmacology leadership with appointment of Susanne Back
The appointment of Susanne Back as Head of In Vivo Pharmacology will further strengthen its bioscience leadership and reinforcing its commitment to delivering...
sygnature discoverystrengthensvivopharmacologyleadership
https://careers.sygnaturediscovery.com/
Welcome to our career site - Sygnature Discovery
career sitesygnature discoverywelcome
https://www.sygnaturediscovery.com/
Sygnature Discovery - Leading Contract Research Organisation
Mar 24, 2026 - Sygnature Discovery is a world-leading integrated drug discovery CRO based in the UK and Canada with headquarters in Nottingham (UK).
sygnature discoverycontract researchleadingorganisation
https://www.sygnaturediscovery.com/sygnature-discovery-completes-major-enhancement-of-high-throughput-chemistry-facilities-following-1-million-investment-2/
Sygnature Discovery Completes Major Enhancement of High-Throughput Chemistry Facilities Following...
sygnature discoverycompletes majorhigh throughputenhancementchemistry
https://www.sygnaturediscovery.com/integrated-drug-discovery/
Integrated Drug Discovery - Sygnature
Feb 12, 2026 - Integrated drug discovery with Sygnature’s multidisciplinary teams. From target to candidate, delivering speed and decision-ready data.
integrated drug discoverysygnature
https://www.sygnaturediscovery.com/therapeutic-areas/oncology/
Oncology and Immuno-Oncology Drug Discovery - Sygnature
Feb 11, 2026 - Sygnature Discovery works right across oncology drug discovery, from target ID and lead op to candidate nomination and clinical positioning.
drug discovery sygnatureoncologyimmuno
https://www.sygnaturediscovery.com/therapeutic-areas/neuroscience/
Neuroscience Drug Discovery - Sygnature
Feb 11, 2026 - Elevate neuroscience drug discovery with Sygnature: tailored strategies, advanced assays, and in-vivo models for CNS success.
drug discovery sygnatureneuroscience